ZIVO BIOSCIENCE, INC. SIGNS CONTRACT WITH ALGATEK ASTURIAS, S.L.
[Spain, USA] ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the co
mmercialization of nutritional and medicinal products derived from proprietary algal strains, announces today that it has contracted with Algatek, S.L., the Spanish algae technology innovator, to conduct a pilot program using proprietary Algatek production technology.
Algatek operates a fully-licensed food-pharma grade facility that will be able to certify ZIVO products and help streamline compliance in the Eurozone and Middle East regulatory environments, expanding potential markets for the Company’s offerings.
Last week, Algatek successfully introduced the ZIVO strain into its production environment at the facility located in Asturias, Spain and will commence scale-up over the next few weeks, when it is expected to cultivate the ZIVO strain in its commercial-scale 96 meter photobioreactors.